Cargando…
Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?
Autores principales: | Reznik, Sandra E., Tiwari, Amit K., Ashby, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326414/ https://www.ncbi.nlm.nih.gov/pubmed/32619723 http://dx.doi.org/10.1016/j.phrs.2020.105055 |
Ejemplares similares
-
Sofosbuvir: A Potential Treatment for Ebola
por: Reznik, Sandra E., et al.
Publicado: (2018) -
Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
por: Reznik, Sandra E., et al.
Publicado: (2022) -
Potential Use of Sofosbuvir in the Prophylaxis for Rabies
por: Reznik, Sandra E., et al.
Publicado: (2020) -
Is Edaravone the Future of Free Radical Scavenging in Inflammatory States?
por: Nair, Abhijit S.
Publicado: (2017) -
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)